KLOW

KLOW 80 mg research blend

KLOW is listed in the VELAIA catalog as an 80 mg multi-component research blend comprising BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg and KPV 10 mg according to the catalog specification.

Research context

• GHK-Cu is studied in tissue-repair and extracellular-matrix signaling.
• BPC-157, TB-500-related research and KPV are investigated in experimental models across distinct biological pathways.
• Evidence for each component should be evaluated separately; the combined KLOW blend does not represent an approved clinical indication.

Documentation

Composition, identity and batch documentation should be verified for the specific lot before research use.

For research purposes only. Not intended for human consumption, self-administration or use as a medicine.